Life Sciences: Is a Blockbuster Wave of M&A Coming?
COVID-19 drove some sectors to the brink of extinction. But in Life Sciences, the pandemic triggered massive digital migration, process innovation and facilities expansion, resulting in refreshingly robust performance – both on balance sheets and in strategic activity.
